OGT 918
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for OGT 918, covering 2017-07-02 to 2017-07-02. Get the full timeline:
Most recent: Clinical Trial Update: OGT 918-006: A Phase I/II Randomized, Controlled Study of OGT 918 in Patients With Neuronopathic Gaucher Disease [Phase 2]